Dr. Hassan Al-Ali
Co-Founder & Chief Scientific Officer
Dr. Al-Ali is a biochemist with expertise in biological, chemical, and computational sciences. He is an expert in assay development, including biochemical and cell-based assays for screening applications. Dr. Al-Ali brings extensive knowledge in the application of informatics and machine learning to early-stage drug discovery, and currently leads several projects within the areas of CNS injury, kidney disease, and cancer.